突破国防部生物技术瓶颈。

Breaching the Department of Defense's Biotech Bottleneck.

机构信息

Diane DiEuliis, PhD, is Senior Research Fellow, and Patrick Terrell is Deputy Director, both at the National Defense University, US Department of Defense Fort Lesley J. McNair, Washington, DC. Peter Emanuel, PhD, is Senior Research Scientist for Bioengineering Combat Capabilities Development, Command Chemical Biological Center, US Department of Defense, US Army, Edgewood, MD.

出版信息

Health Secur. 2020 Mar/Apr;18(2):139-144. doi: 10.1089/hs.2019.0150.

DOI:10.1089/hs.2019.0150

PMID:32324069

Abstract

The global biotechnology revolution offers a profusion of promising innovations for the US Department of Defense (DoD). As with other emerging technologies, the commercial market, rather than defense, is driving the evolution of biotechnology products, and the ability to harness biotechnology for defense benefits has been hampered by strategic confusion in DoD. Here we describe a set of high-level challenges and a set of potential solutions that could bring innovative biotechnology closer to reality for the warfighter and DoD writ large.

摘要

全球生物技术革命为美国国防部（DoD）带来了丰富的有前途的创新。与其他新兴技术一样，商业市场而不是国防推动了生物技术产品的发展，而利用生物技术为国防带来好处的能力一直受到国防部战略混乱的阻碍。在这里，我们描述了一系列高层级的挑战和一系列潜在的解决方案，这些方案可以使创新的生物技术更接近作战人员和整个国防部的现实。